IAG is Leading AI powered Drug Development and Precision Medicine

Enhancing preclinical drug discovery with artificial intelligence - ScienceDirect

We are Leading AI powered Drug Development and Precision Medicine

AI-powered therapeutic target discovery: Trends in Pharmacological Sciences

TargTex and IAG, Image Analysis Group Announce Partnership

Press Release – TargTex to partner with IAG to apply AI to assess the effects of a novel clinical candidate in Glioblastoma Patients

IAG's CEO, Dr. Kubassova Guest Starring on the RP HealthCast Podcast

The Age of AI has begun

Artificial Intelligence in Precision Medicine: A Perspective in Biomarker and Drug Discovery

First Wholly AI-Developed Drug Enters Phase 1 Trials

Artificial Intelligence for Drug Toxicity and Safety: Trends in Pharmacological Sciences

AI in Drug Development Q4 2022

Nuclear Medicine and Molecular Imaging are Driving Precision Medicine

Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology - ScienceDirect

Next Decade's AI-Based Drug Development Features Tight Integration of Data and Computation

WPD Pharmaceuticals, Inc. & IAG, Image Analysis Group will Deploy AI and Quantitative Imaging to Advance New GBM Treatment